Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000213742 | SCV000273406 | likely benign | Hereditary cancer-predisposing syndrome | 2019-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000235477 | SCV000293834 | likely benign | not provided | 2019-05-09 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 10621852, 28861920, 16531411, 19748724, 24729566, 26206375, 29979965, 12826609, 30840781) |
Labcorp Genetics |
RCV000470622 | SCV000545295 | likely benign | Li-Fraumeni syndrome | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000213742 | SCV000903937 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000213742 | SCV002582569 | likely benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002288848 | SCV002582871 | likely benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing |